Article
Dextromethorphan test for evaluation of congenital predisposition to lung cancer.
Chest - 1 Feb 1994
Puchetti V, Faccini G B, Micciolo R, Ghimenton F, Bertrand C, Zatti N
Abstract excerpt
We report the results of an investigation conducted in 992 healthy control subjects (854 adults and 138 adolescents) and in 116 subjects with lung cancer (LC) for the purpose of detecting those individuals with a possible genetic predisposition to lung cancer. The test consists of the oral administration of 64 mumol of dextromethorphan (DMP) with collection of urine samples over the following 8-h period and urine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
